eli lilly news - Search News

Lilly Gets Approval For Its Alzheimer's Disease Drug Kisunla

Eli Lilly’s Alzheimer’s treatment Kisunla wins approval in Japan

Japan, with its rapidly aging population, is expected to have more than 5 million patients with dementia by 2030. Alzheimer’s is the most common form of dementia, accounting for more than 67% of cases,

Reuters on MSN · 1d

Eli Lilly's Alzheimer's drug approved in Japan

Eli Lilly said on Tuesday Japan's health ministry has approved donanemab, its drug for Alzheimer's disease, providing patients with another treatment option after Eisai and Biogen's Leqembi received the nod in September last year.

Pharmaceutical Technology · 4h

MHLW approves Eli Lilly’s Kinsula to treat Alzheimer’s in Japan

Eli Lilly has received approval in Japan for Kisunla (donanemab-azbt) to treat early symptomatic Alzheimer's disease.

MarketWatch · 1d

Eli Lilly Gets Japan OK for Kisunla Alzheimer's Disease Drug

Eli Lilly on Tuesday said Japan's Ministry of Health, Labour and Welfare Japan approved Kisunla for adults with early symptomatic Alzheimer's, including those with mild cognitive impairment as well as people with the mild dementia stage of the memory-robbing disease.

Medical News Today · 1d

EBGLYSS for eczema: What to know about the newly FDA-approved drug from Eli Lilly

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can significantly improve symptoms.

24/7 Wall St21h

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 594.50% and ...

Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)

With a market capitalization of over $800 billion, Eli Lilly (NYSE: LLY) is the largest pharmaceutical company in the world.

Eli Lilly Is Finally Cheap, Warranting An Upgrade To Buy

Eli Lilly's long-term growth prospects are strong with improved supply, new growth opportunities, and competitive positioning ...

Eli Lilly urges court to toss $183 mln Medicaid fraud judgment

Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...

Prediction: This Will be Eli Lilly's Next Big Move.

This is thanks to Lilly's dominance in the billion-dollar weight loss drug market. Lilly's Mounjaro and Zepbound have helped ...

USA Today9d

New eczema drug from Eli Lilly receives FDA approval for children and adults

On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 and ...

Ibj.com7d

Eli Lilly requests records of people who took copies of its weight-loss drug

The letter is the latest sign that the battle between the brand-name drug manufacturers and the companies that make and sell ...

Business Insider4h

Lilly Reports New Long-term Data For Its Atopic Dermatitis Treatment Ebglyss

(RTTNews) - Eli Lilly and Company (LLY) Wednesday reported new long-term data for its atopic dermatitis treatment Ebglyss. The results were reported from ADjoin long-term extension study. In the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics